Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
CARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology.
Related news for (ASAPF)
- Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
- Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
- Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
- Aurora Spine Corporation Announces Record First Quarter Financial Results
- Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results